Focused on the treatment of digestive and cardiovascular diseases
Focused on the treatment of digestive and cardiovascular diseases
Our mission is the research, development and commercialization of mercialización de products of natural origin with demonstrated therapeutic efficacy (nutraceuticals)*, offering comprehensive solutions for different pathologies.
We want to become the standard of treatment for all our pathologies and continue to develop nutraceuticals of the highest quality, making our products available to healthcare professionals in order to improve the quality of life of their patients.
Our History
In 2019 Koncare Biotech is born with the objective and ambition of becoming a leading company in the care and improvement of the quality of life of our patients.
All this, under the prism of natural products guaranteed under strict quality standards, both by our internal manufacturing & development controls as well as by regulatory authorities.
In this way, our ambition becomes a reality by launching two key products in digestive pathology, aimed at alleviating two ailments that have a very negative impact on quality of life.
In our desire to find the best solution, DISIBEX was born as a treatment for dyspepsia (a very frequent pathology which was only partially addressed and improved by the drugs on the market).
At the same time, we address another symptom that produces enormous deterioration in the quality of life, which is Irritable Bowel Syndrome (estimated to be suffered by around 11% of the general population). Many of these patients do not seek medical assistance, causing a chronification of the dysfunction and great discomfort for those who suffer from it. SIIK was born from this dilemma, becoming a standard of treatment for our patients and healthcare professionals, with whom we work hand in hand to offer the best possible solutions.
Commitment to R&D+i
This constant challenge leads us to continue investigating.
The close collaboration with the most prominent Canadian companies in the sector allows us to be at the forefront in R&D+i, being able to offer the latest scientific advances.
It was born in 2020 in response to the preventive care treatment of cardiovascular pathology, in the control and decrease of LDL cholesterol and in the increase of HDL in our patients.
We are convinced that it is and will become the standard of treatment for hypercholesterolemia, improving the quality of life of our patients and reducing the adverse effects that occur with current treatments, ensuring greater efficacy and safety.
The microbiota is the set of microorganisms that coexist in a certain habitat, in this case the human intestine. The genetic material of the microorganisms that make up our microbiota is composed of more than 3.3M of genes (microbiome) and perform functions of nutrition, metabolism, protection and development in our body.
Very soon, we hope to share excellent news about agreements on the detection and treatment of the over-expression of this bacterial growth.
None of this would be possible without our researchers and the excellent human capital that makes up Koncare Biotech. We are very proud of our team, but above all, our great pride is helping our patients.
Helping you.
Commitment to R&D+i
This constant challenge leads us to continue investigating.
The close collaboration with the most prominent Canadian companies in the sector allows us to be at the forefront in R&D+i, being able to offer the latest scientific advances.
It was born in 2020 in response to the preventive care treatment of cardiovascular pathology, in the control and decrease of LDL cholesterol and in the increase of HDL in our patients.
We are convinced that it is and will become the standard of treatment for hypercholesterolemia, improving the quality of life of our patients and reducing the adverse effects that occur with current treatments, ensuring greater efficacy and safety.
The microbiota is the set of microorganisms that coexist in a certain habitat, in this case the human intestine. The genetic material of the microorganisms that make up our microbiota is composed of more than 3.3M of genes (microbiome) and perform functions of nutrition, metabolism, protection and development in our body.
Very soon, we hope to share excellent news about agreements on the detection and treatment of the over-expression of this bacterial growth.
None of this would be possible without our researchers and the excellent human capital that makes up Koncare Biotech. We are very proud of our team, but above all, our great pride is helping our patients.
Helping you.
Nutraceuticals
The term «nutraceutical» is used to refer to any food or food derivative with health benefits additional to its nutritional value.
They are generated through biotechnological processes, after the isolation and purification of nutrients and/or bioactive substances. From them, we can expect the stimulation of general well-being, the prevention and control of the symptoms of diseases and conditions, the delay of aging and the increase in life expectancy, as well as the support of the functions and integrity of the body.
Nutraceuticals comply with the following principles:
This term encompasses natural products ranging from herbs and derivatives to pure foods, isolated nutrients, dietary supplements, and specific diets.
Thus, the following categories of nutraceuticals can be established:
FUNCTIONAL FOODS
MEDICINAL FOODS
DIETARY SUPLEMENTS